The corrections of the List, as issued by the Institute, include, without limitation, the found defects for the TYVERB product that should not be included in the List valid as of 1 August 2012, as its temporary reimbursement has expired.
This correction is made in compliance with Section 39n(3) of the Act and becomes effective on the day it is published on the official notice board. The List’s correction lays down the full list of medicinal products (MPs) and foods for special medicinal purposes (FSMPs) reimbursed from the public health insurance system subject to the Institute’s decision, including their maximum or announced ex-factory prices, the amount and the terms of reimbursement, incl. their highest possible reimbursement for the end consumer, along with the amount of the extra payment in the eligible limit. In addition, the List contains the basic reimbursements of reference groups and explains the reasoning behind the basic reimbursements, along with a full list of the medicinal products and foods for special medicinal purposes included in the reference groups.
List of prices of medicinal products and f